Literature DB >> 27619717

Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients).

Fabio Mangiacapra1, Elena Panaioli2, Iginio Colaiori2, Elisabetta Ricottini2, Angelo Lauria Pantano2, Paolo Pozzilli2, Emanuele Barbato2, Germano Di Sciascio2.   

Abstract

Entities:  

Keywords:  diabetes mellitus; endothelium; platelet aggregation inhibitors

Mesh：

Substances：

Year:  2016        PMID： 27619717     DOI： 10.1161/CIRCULATIONAHA.116.023743

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  Interaction between platelets and endothelium: from pathophysiology to new therapeutic options.

Authors:  Michalis Hamilos; Stylianos Petousis; Fragiskos Parthenakis
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

Review 2.  The Interplay of Endothelial P2Y Receptors in Cardiovascular Health: From Vascular Physiology to Pathology.

Authors:  Cendrine Cabou; Laurent O Martinez
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

Review 3.  A Review of the Role of the Antiplatelet Drug Ticagrelor in the Management of Acute Coronary Syndrome, Acute Thrombotic Disease, and Other Diseases.

Authors:  Luyuan Tao; Shijia Ren; Li Zhang; Wenhua Liu; Yi Zhao; Changgong Chen; Xiang Mao; Zili Chen; Xingjian Gu
Journal:  Med Sci Monit       Date:  2022-05-16

4.  Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: a landmark analysis.

Authors:  Fabio Mangiacapra; Iginio Colaiori; Elisabetta Ricottini; Antonio Creta; Giuseppe Di Gioia; Ilaria Cavallari; Edoardo Bressi; Marialessia Capuano; Emanuele Barbato; Germano Di Sciascio
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

5.  Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease.

Authors:  Gianluca Campo; Francesco Vieceli Dalla Sega; Rita Pavasini; Giorgio Aquila; Francesco Gallo; Francesca Fortini; Elisabetta Tonet; Paolo Cimaglia; Annamaria Del Franco; Gabriele Pestelli; Alessandro Pecoraro; Marco Contoli; Cristina Balla; Simone Biscaglia; Paola Rizzo; Roberto Ferrari
Journal:  Thromb Haemost       Date:  2017-03-23       Impact factor: 5.249

6.  Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease.

Authors:  Charalambos Vlachopoulos; Christos Georgakopoulos; Panagiota Pietri; Nikolaos Ioakeimidis; Michael Koutouzis; Sophia Vaina; Konstantinos Aznaouridis; Konstantinos Toutouzas; George Latsios; Dimitrios Terentes-Printzios; Aggeliki Rigatou; Dimitris Tousoulis
Journal:  J Am Heart Assoc       Date:  2019-06-05       Impact factor: 5.501

Review 7.  Purinergic interplay between erythrocytes and platelets in diabetes-associated vascular dysfunction.

Authors:  Zhichao Zhou
Journal:  Purinergic Signal       Date:  2021-08-19       Impact factor: 3.765

8.  The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis.

Authors:  Baoyi Guan; Lin Zhao; Dan Ma; Yixuan Fan; He Zhang; Anlu Wang; Hao Xu
Journal:  Front Cardiovasc Med       Date:  2022-01-26

Review 9.  A review of the effects of ticagrelor on adenosine concentration and its clinical significance.

Authors:  Mohammed Ahmed Akkaif; Mei Li Ng; Muhamad Ali Sk Abdul Kader; Nur Aizati Athirah Daud; Abubakar Sha'aban; Baharudin Ibrahim
Journal:  Pharmacol Rep       Date:  2021-07-20       Impact factor: 3.024
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.